Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Genomic Sequencing in Anatomically Normal Fetuses

NCT: NCT06211348 · RECRUITING

NCT IDNCT06211348
StatusRECRUITING
Start Date2024-01-01
Completion2030-01

Brief Summary

This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.

Frequently Asked Questions

What is Genomic Sequencing in Anatomically Normal Fetuses?

Genomic Sequencing in Anatomically Normal Fetuses is a clinical trial registered under NCT06211348. Current status: RECRUITING.

What is the status of NCT06211348?

The current status of NCT06211348 (Genomic Sequencing in Anatomically Normal Fetuses) is: RECRUITING.

When did Genomic Sequencing in Anatomically Normal Fetuses start?

Genomic Sequencing in Anatomically Normal Fetuses started on 2024-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑